Loading, Please Wait...
MISSION VIEJO, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced an agreement to provide neuropsychiatric testing for the Inova Health System (Inova), a global leader in personalized health serving more than 2 million people each year across the Washington, DC, metro area and beyond. The program will begin with Inova’s Mount Vernon Hospital, where PEER testing will be provided for psychiatric outpatient and inpatient services.
Tom Pianta, Strategic Growth Officer for Inova Mount Vernon Hospital, summarized the goals of the program: “We had excellent physician feedback from our pilot program in 2017 and have decided to move forward with a broader implementation of PEER services, starting here at Mount Vernon. Inova intends to be a leading provider of effective behavioral health services in the Washington metropolitan area by deploying tools like PEER.”
George Carpenter, CEO of MYnd Analytics Inc., added “We are delighted to work with Inova’s outstanding team of clinicians and administrators to roll out PEER across their network. As one of the pre-eminent health systems in the country serving over 2 million patients each year, Inova is at the forefront of personalized medicine and leveraging technology to improve patient outcomes. This latest partnership is further validation of our platform technology and we see a growing number of leading-edge health systems, like Inova, who seek to improve the targeting of therapies and effectiveness of treatment.”
About Inova Mount Vernon Hospital
Inova Mount Vernon Hospital is a 237-bed hospital offering patients convenience and state-of-the-art care in a community environment. Our hospital sits on 26 acres of beautifully landscaped open space, where patients can find moments of serenity in our specially designed gardens.
Inova Mount Vernon Hospital is home to the nationally recognized Inova Joint Replacement Center and Inova Rehabilitation Center. Both are ranked among the top orthopedic and rehabilitation programs in the country. It also houses the Inova Wound Healing Center, the Washington, DC region’s largest and most experienced wound healing team.
Inova is a global leader in personalized health, which leverages precision medicine to predict, prevent and treat disease, enabling individuals to live longer, healthier lives. At Inova, we serve more than 2 million people each year from throughout the Washington, DC, metro area and beyond.
We are shaping the future of health through our integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes. Our commitment to health and wellness is further reflected in our sustainable practices. Inova is home to world-class researchers, expert medical specialists and renowned scientists, who are driving innovation to improve patient care, prevent disease and promote wellness. For more information, visit inova.org, or find Inova on Facebook, Twitter and LinkedIn.
About MYnd Analytics
MYnd Analytics, Inc. (www.myndanalytics.com) is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the Company’s original physician-developed database, there are now more than 39,000 outcomes for over 11,000 unique patients in the PEER registry. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications.
MYnd also operates its wholly owned subsidiarity Arcadian Telepsychiatry Services, LLC which manages a suite of services including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. Arcadian utilizes patient engagement and re-engagement strategies so that care is effectively completed, helping to comfortably move inpatient care to outpatient, assisting patients in readjusting to their life routine, as well as reducing wait times for mental health treatment. Arcadian’s customer base includes major health plans, health systems, and community-based organizations.
To read more about the benefits of this patented technology for patients, physicians and payers, please visit: www.myndanalytics.com.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties, such as MYnd's ability to successfully expand into various market channels, the ability of its products to successfully target objectivity and increased efficiency in the treatment of depression and other mental health and psychiatric illnesses and MYnd's ability to expand globally in areas where there is an opportunity to improve treatment in mental health, to continue to protect and enforce its patents, as well as those risks and uncertainties set forth in MYnd's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.
Crescendo Communications, LLC
Tel: +1 (212) 671-1020